Navigation Links
Latest Hyaluronic Acid Filler Takes the Sting Out of Beauty
Date:7/10/2008

N. DALLAS and PLANO, Texas, July 10 /PRNewswire/ -- In the war of the injectable beauty fillers, the battle will soon become heated with the arrival of the newest hyaluronic acid injectable gel filler in the U.S. aesthetics market. Anika Therapeutics' FDA-approved ELEVESS(TM) enters the arena with a clear combat advantage: incorporation of lidocaine with their hyaluronic acid (H.A.) gel, to improve injection comfort.

Many cosmetic physicians, including Jeffrey Adelglass, MD, FACS of SKINTASTIC(TM) Medical & Surgical Rejuvenation Center of Plano, Texas routinely mix lidocaine with some dermal fillers, or inject lidocaine as a nerve-block prior to filler injection, primarily in sensitive, nerve-rich areas such as the lips and eye areas. Elimination of mixing and nerve-blocks saves time and work for the doctor, and reduces the patient's wait.

Although not the first FDA-approved hyaluronic acid filler/lidocaine formulation in the U.S., ELEVESS(TM) claims to provide long-lasting results. Lack of durability is a chief complaint of frequent H.A. filler users. Currently approved for sale in the U.S., European Union and in Canada, ELEVESS(TM) utilizes a proprietary cross-linking technology that creates a highly-concentrated H.A. formulation which suggests the potential of longer durability in the body. Allergan, the makers of Botox(R), currently produce Juvaderm(R) with lidocaine for the European Union, but U.S. approval of their H.A./lidocaine formulation is forthcoming. A U.S. dermal filler already utilizing lidocaine is non-resorbable-ArteFill (a non-H.A. filler) by Artes Medical; Artes was chosen by Anika Therapeutics to be a U.S. distributor for ELEVESS(TM). Dr. Adelglass is a clinical researcher for Artes Medical, and serves on Artes' Scientific Advisory Board.

Experience counts. Dr. Adelglass was the first Texas physician to recently achieve simultaneous Diamond pinnacle-level status as a Botox(R) injector and Triple-Platinum status with Medicis, the makers of Restylane(R) and Perlane(R) injectable H.A. fillers. Dr. Adelglass is a member of the Star Program-a select group of cosmetic physicians specially-trained to work with new Evolence(R) collagen filler, and is an exclusive Black Card member of Radiesse(R) physician injectors. He serves on the scientific advisory boards of most, if not all U.S. dermal filler companies, and on the National Education Foundation for Allergan, instructing other cosmetic physicians to safely administer Botox(R) using his well-honed injection techniques. Dr. Adelglass is also an official training instructor for SmartLipo(TM) laser body sculpting, the DOT Fractional skin resurfacing laser, ArteFill(R) non- resorbable, and Juvederm(R) fillers. With his level of experience, it's no wonder that many of the representatives of these companies, with all their available options, select Dr. Adelglass as their own cosmetic physician of choice.

The cost of ELEVESS(TM) is expected to be comparable to that of other popular hyaluronic acid fillers. Call (972) 620-3223 to be added to a waiting list to receive a complimentary ELEVESS(TM) evaluation (and special introductory offer). ELEVESS(TM)-related questions can be directed to skintastic@skintastic.com. Skintastic is located in the Presbyterian Plano Center for Diagnostics and Surgery at 6020 W. Parker, Suite 400 in Plano, Texas.


'/>"/>
SOURCE SKINTASTIC(TM) Medical and Surgical Rejuvenation Center
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Licensed Rx Announces Latest Customer Savings Scheme
2. Lifeclinic to Feature Latest Health Stations at McKesson's Pharmacy of the Future
3. Latest Research Shows Strong Consumer Demand for Organic Foods
4. Cardiologist Praises Latest Resveratrol/Red Wine Research
5. The DataTrace(R) RF System, the Latest High Performance Radio Data Logger for Real-Time, Process Data Collection, Reporting, and Analysis Is Launched
6. Agilysys Announces Latest Version of Lodging Management System(R) (LMS)
7. Cardiva Medical, Inc. to Present at the Investment In Innovation (In3) Medical Device Summit on June 18, 2008 in San Francisco, CA; Announces the Completion of Its Latest Phase in Its US Sales Force Expansion
8. Latest research on allergies: Specific immunotherapy can help
9. Service Employee Unions Latest Attack on RNs Parrots McCains Attack on Obamas Health Plan
10. Latest Advances in Infection Prevention and Control to be Presented in Denver, CO at Worlds Largest Annual Infection Prevention Conference, June 15-19, 2008
11. Can SonicMood Help to Significantly Lower High Blood Pressure? The Latest Research Answers With a Resounding YES!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice under Dr. ... board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood Bank (TCBB), a ... and delivery team at Women’s Hospital at Renaissance in Edinburg for their outstanding efforts ... hospital and decide to donate. , “Women’s Hospital at Renaissance has been a ...
(Date:4/28/2017)... Yorba Linda, Ca (PRWEB) , ... April 28, ... ... entities with cardiac or hERG liability could substantially improve drug safety and minimize ... will be provided for validating ion channel inhibition using cell lines and for ...
(Date:4/28/2017)... ... ... Bill Howe started his sewer and drain company in 1980 focusing heavily ... team, the Bill Howe brand was born and they began cultivating their mission to ... the San Diego community in which they worked, lived and were raising their daughters. ...
(Date:4/28/2017)... Pensacola, FL (PRWEB) , ... April 28, 2017 ... ... Tampa, Florida are conducting a pilot study of ActiGraph’s CentrePoint Data ... ActiGraph is a leading provider of clinical-grade wearable activity and sleep monitoring solutions ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and ... ... valued at US$ 7,167.6 Mn in 2015, and is expected ... CAGR of 5.6% from 2016 to 2024. ...
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market is ... Low drug registration cost in Latin American countries and continuous ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most ... the forecast period Mobile X-Ray segment is the ... X-Ray devices market, which is estimated to be valued at ... CAGR of 7% over the forecast period. Mobile X-Ray segment ... US$ 100 Mn in 2017 over 2016. The segment,s revenue ...
Breaking Medicine Technology: